-
The Future Of Nano Technology
Categories
- Ai
- Alan Watts
- Anatomy
- Andropause
- Anti-Aging Medicine
- Arthritis
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ataxia
- Autism
- Biochemistry
- BioEngineering
- Biotechnology
- Bitcoin
- Chemistry
- Cryonics
- Cryptocurrency
- David Sinclair
- Dementia
- Diet Science
- Diseases
- Eczema
- Elon Musk
- Futurism
- Gene Medicine
- Gene Therapy
- Gene therapy
- Genetic Medicine
- Genetic Therapy
- Global News Feed
- Healthy Lifestyle
- Healthy Living
- HGH Physicians
- Hormone Optimization
- Hormone Replacement Therapy
- Hormone Replacement Treatment
- Human Genetic Engineering
- Human Immortality
- Human Longevity
- Human Reproduction
- Hypogonadism
- Hypopituitarism
- Hypothyroidism
- Immortality
- Immortality Medicine
- Inflammation
- Injectable Growth Hormone
- Integrative Medicine
- Life Skills
- Longevity
- Longevity Medicine
- Low T
- Machine Learning
- Mars Colony
- Medical School
- Menopause
- multiple-sclerosis
- Nano Medicine
- Nanomedicine
- Nanotechnology
- Neurology
- Parkinson's disease
- Pharmacogenomics
- Protein Folding
- Psoriasis
- Quantum Computing
- Regenerative Medicine
- Resveratrol
- Sermorelin Physicians
- Singularity
- Spacex
- Stem Cell Therapy
- Stem Cells
- Stemcell Therapy
- Testosterone
- Testosterone Physicians
- Transhuman
- Transhumanism
- Transhumanist
- Uncategorized
- Veganism
- Vegetarianism
- Vitamin Research
- Wellness
-
Recent Posts
- Googles Astra is its first AI-for-everything agent – MIT Technology Review
- Generative AI Is Totally Shameless. I Want to Be It – WIRED
- Verizon Expects to Double Network Thanks to AI Demand – PYMNTS.com
- Google’s new LearnLM AI model focuses on education – The Verge
- Google unveils Project Astra chatbot tech and brings ‘AI overview’ to search for all U.S. users – Fortune
Archives
Popular Key Word Searches
- centraltph
- bicarbonate and growth immunity ray peat
- vrcc neurology
- bibliotecapleyades/amrita-longevity-immortality
- cbr xmen anatomy
- Medical genetics wikipedia
- immortality medicine
- GrabPay
- Grab Pay Philippines
- GrabPay Vietnam
- GrabPay Philippines
- dr weil psoriasis
- what does recovered mean covid-19
- tony pantalleresco
- tony pantalleresco herbalist book
- herbsplusbeadworks
- herbsplusbeadworks website
- hailie vanderven
- princeton longevity center scam
- aetna genetic testing policy
- anatomy of hell
- biggie
- longevity claims
- augmentinforce tony pantalleresco
- tony pantalleresco website
Search Immortality Topics: |
Category Archives: Genetic Medicine
How to improve R&D productivity: the pharmaceutical industry’s grand challenge
Posted in Genetic Medicine
Comments Off on How to improve R&D productivity: the pharmaceutical industry’s grand challenge
IBM Files Application to Patent The Patent
Ever heard of people getting obnoxious amount of money to conduct research or get a PhD for pointless research. Thats what came to my mind when I first came across this news from IBM.
Just remind these were some of the winning ideas that funded by Government in US for Research papers and PhDs
1. the National Science Foundation once gave $100K grant to research why American players go to greater lengths to mod the popular MMO than do Chinese WoW players.
2. Pressures Produced When Penguins Pooh — Calculations on Avian Defaecation”, Polar Biology, 2004
3. Suicide rates are linked to the amount of country music played on the radio, , Medicine, 2005
4. Rats can’t always tell the difference between Japanese spoken backwards and Dutch spoken backwards, winner, Linguistics, 2007
As much as I stand to loose a chance to get a job at IBM by this post, its so hard not to think loud, and ask IBM what the heck was wrong with your brains, when you made the decision to patent the patent.
The Original Post Pasted from http://www.tomshardware.com/news/ibm-patents-the-patent,11868.html
IBM Files Application to Patent The Patent Process
6:40 PM – January 3, 2011 by Douglas Perry – source: ConceivablyTech
Reading through IT patents these days requires patience and tolerance. When you can patent common sense, there is clearly something wrong with the system. But as long as no changes are being made, you are inviting people to exploit what is available and IBM has just demonstrated what may be possible, if one of their most recent patent applications is accepted by the USPTO.
The company felt it would be beneficial to patent the patent strategy process all the way from training inventors, to competitor monitoring and protecting (i.e. suing someone) a patent from infringement. This patent does not describe anything new, but a strategy that is being pursued by anyone who owns a patent and especially patent trolls or people like Paul Allen, who is just taking another shot at suing Google for patent infringement.
The patent application could mean that IBM in fact is working on a software that automates patent management or the company simply felt it was necessary to patent the idea of filing a patent and treating it in the way it could be considered common sense. It is especially revealing how much focus the inventor put on a “defend” module that implies a lawsuit strategy. It would take a genius to figure that out.
Reading through this patent is a good lecture how a patent these days should not look like. IBM is the natural place for this idea as there is no other company that files for as many patents (and receives as many patents) as IBM does. But if the patent idea gets approved
Posted in Genetic Medicine
Comments Off on IBM Files Application to Patent The Patent
Adverse Events in Hospitals- United States Department of Health Report slams current measures in US hospitals
OFFICE OF , INSPECTOR GENERAL of US Department of Health and Human Services, released a report on the national incidence of adverse events for hospitalized Medicare beneficiaries, the preventability of such events, and associated costs to Medicare.
The report released last month month found that one in seven of the patients experienced an adverse event such as excessive bleeding, a hospital-acquired infection or aspiration pneumonia. Those events, both preventable and not preventable, led to about 180,000 deaths a year.
The complete report available at
http://oig.hhs.gov/oei/reports/oei-06-09-00090.pdf
Posted in Genetic Medicine
Comments Off on Adverse Events in Hospitals- United States Department of Health Report slams current measures in US hospitals
PharmaNet unveils touch screen capable data capture platform for Phase I Clinical Trials
The implementation of this platform enables rapid study set-up, automated CRF generation and better study recruitment and communication tools for general and special populations. Mobile workstations allow for rapid data entry and data is captured directly using bar codes and interfaces to medical equipment, such as blood pressure monitors. The Initiator platform also interfaces with the Company’s LIMS, as well as its diagnostic laboratory software and investigational drug management system.
Detailed PR available at PharmNet website
http://phx.corporate-ir.net/phoenix.zhtml?c=234619&p=irol-newsArticle&ID=1506686&highlight=
Posted in Genetic Medicine
Comments Off on PharmaNet unveils touch screen capable data capture platform for Phase I Clinical Trials
Sanofi-Aventis ties up with Oxford Univ for oncology research in India
Sanofi-Aventis and Oxford University have entered into an agreement with INDOX, an academic oncology network to conduct oncology clinical and translation research in India.
The company said that through this partnership, Sanofi-Aventis will have access to experience and expertise of India’s top oncologists which will help the company in conducting clinical research. “The collaboration between sanofi-aventis, Oxford University and the Indian Cancer Centers fosters a model for academic researchers and industry to work together for the benefit of patients,” said Debasish Roychowdhury, MD, Senior Vice President, Head of Oncology, sanofi-aventis.
Sanofi-Aventis said that the company will provide financial assistance to Oxford University to manage INDOX’s eigh cancer reseach centres in India. The university, on its part, will provide training and support to investigators and reseach coordinators to help in carrying out the research.
INDOX is a partnership between Oxford University and India’s top eight cancer research centres in India.
Posted in Genetic Medicine
Comments Off on Sanofi-Aventis ties up with Oxford Univ for oncology research in India
trends in the life sciences and pharma research and development outsourcing (RDO)
Vicki Phelan, Managing Director, Pharmaceutical and Life Sciences Practice
with Stan Lepeak, Managing Director, Global Research
Trends in the life sciences and pharma research and development outsourcing (RDO)
The complete report is available at http://goo.gl/MgVBu
Posted in Genetic Medicine
Comments Off on trends in the life sciences and pharma research and development outsourcing (RDO)